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Abstract. We present a SIR+ASI epidemic model to describe the interaction between human and dengue fever mosquito
populations. A control strategy in the form of vaccination, to decrease the number of infected individuals, is used. An optimal
control approach is applied in order to find the best way to fight the disease.
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INTRODUCTION
Dengue fever is a vector borne disease, which has become an increasingly public health problem that
carries a huge financial burden to the governments. Currently, the only way of controlling the disease is
to minimize the vector population. Dengue vaccine for effective prevention and long term control under
development, is expected to be the solution. Dengue transcends international borders and is emerging rapidly
as a consequence of globalization and climate changes. It is a disease of great complexity, due to the
interactions between humans, mosquitoes, and various virus serotypes as well as efficient vector survival
strategies. The four serotypes, known as DEN1 to DEN4, constitute a complex of flaviviridae transmitted by
Aedes mosquitos, specially Aedes Aegypti. Infection by any of the four serotypes induces lifelong immunity
against reinfection by the same type, but only partial and temporary protection against the others. Sequential
infection by different serotypes could lead to a more severe dengue episode: dengue hemorrhagic fever
(DHF).
Vector control remains the only available strategy against dengue. Despite integrated vector control with
community participation, along with active disease surveillance and insecticides, there are only a few exam-
ples of successful dengue prevention and control on a national scale [1]. To make matters worse, the levels of
resistance of Aedes Aegypti to insecticides has increased, which imply shorter intervals between treatments,
and only few insecticide products are available in the market because of high costs for development and
registration and low returns.
For long time, the evaluation of global dengue disease burden was limited and the stakeholders considered
the potential market for the dengue vaccine to be small. By the end of 20th century, with the increase
in dengue infections as well as the prevalence of all four circulating serotypes, faster development of a
vaccine became a serious concern [2]. It is agreed that a vaccination program not only protects directly
the individual, but also indirectly the population, which is called herd immunity. As a consequence of
vaccination, the occurrence of epidemics would decrease relieving health facilities. However, constructing
a successful vaccine for dengue has been challenging. Not only is the knowledge of disease pathogenesis
insufficient, but also the vaccine must protect against all serotypes so that the level of DHF doesn’t increase.
OPTIMAL CONTROL OF THE EPIDEMIOLOGICAL MODEL
Two types of population were considered: hosts and vectors. The hosts (humans) are divided into three com-
plementary classes: susceptible, Sh(t), individuals who can contract the disease; infected, Ih(t), individuals
capable of transmitting the disease to others; and resistant, Rh(t), individuals who have acquired immunity
at time t. The total number of hosts is constant, which means that Nh = Sh(t)+ Ih(t)+Rh(t). Similarly, the
model has also three compartments for the vectors (mosquitoes): Am(t), which represents the aquatic phase
of the mosquito (including egg, pupae and larvae) and the adult phase of the mosquito, with Sm(t) and Im(t),
susceptible and infected, respectively. It is also assumed that Nm = Sm(t)+ Im(t). The model is described by
an initial value problem with a system of six differential equations:8>>>>>>>>>><>>>>>>>>>>:
dSh
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
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
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dIh
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(1)
The recruitment rate of human population is noted by mhNh. The natural death rate for humans and
mosquitoes, aquatic and adult phase, is described by the parameters mh, mm and mA, respectively. We as-
sume that B is the average daily biting (per day) of the mosquito whereas bmh and bhm are related to the
transmission probability (per bite) from infected mosquitoes to humans and vice versa. By j we denote the
number of eggs at each deposit per capita (per day). The recovery rate of the human population is denoted
by hh. The maturation rate from larvae to adult (per day) is denoted by hA. The vaccine coverage of the
susceptible is represented by u (the control variable). The factor s represents the level of inefficacy of the
vaccine: for s = 0 the vaccine is perfectly effective, while s = 1 means that the vaccine has no effect at all.
The main aim of this work is to study the optimal vaccination strategy considering both the costs of treatment
of infected individuals and the costs of vaccination. So, the objective functional is
minimize J[u] =
Z t f
0

gIIh(t)2+ gVu(t)2

dt; (2)
where gI and gV are positive constants representing the weights of the costs of treatment of infected and
vaccination, respectively. Let li(t), with i = 1; : : : ;6, be the co-state variables. The Hamiltonian for the
present optimal control problem is given by
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
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
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(3)
TABLE 1. Values of the cost functional (2)
Method optimal control no control (u 0) upper control (u 1)
Direct (DOTcvpSB) 0.146675 0.674555 364.940488
Indirect (backward-forward) 0.113137 0.357285 365.00046
By the Pontryagin maximum principle [3], the optimal control u should be the one that minimizes, at each
instant t, the Hamiltonian given by (3), that is, H (x(t);l (t);u(t)) = minu2[0;1]H (x(t);l (t);u). The
optimal control, derived from the stationary condition ¶H¶u = 0 and considering 0 u 1, is given by
u =min

1;max

0;
(l1 l3)(Sh sRh)
2gV

:
Substituting the optimal control u into the state system (1) and the adjoint system l 0i (t) =  ¶H¶xi , i.e.,8>>>>>>>>>>><>>>>>>>>>>>:
dl1
dt = (l1 l2)

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we obtain the corresponding x and l i , i= 1; : : :6, with the help of the transversality conditions l i (t f ) = 0,
i= 1; : : : ;6 (see [3] for details).
NUMERICAL SIMULATION AND DISCUSSION
The simulations were carried out using the following values: Nh = 480000, B = 0:5, bmh = 0:3, bhm = 0:3,
mh = 1=(71 365), hh = 1=3, mm = 1=10, k = 3, m = 3, Nm = mNh, j = 6, and t f = 365 days. It was
considered that the vaccine is imperfect with a level of inefficacy of s = 0:15. The initial conditions for
the ordinary differential system were: Sh(0) = Nh  216, Ih(0) = 216, Rh(0) = 0, Am = k Nh, Sm(0) = Nm
and Im(0) = 0. The optimal control problem was solved using two methods: direct and indirect. For an
introduction to direct and indirect methods in optimal control we refer the reader to [4, 5]. The direct method
uses the optimal functional (2) and the state system (1) and was solved by DOTcvpSB [6]. It is a toolbox
implemented in MatLab, which uses an ensemble of numerical methods for solving continuous and mixed-
integer dynamic optimization problems. The indirect method we used is an iterative method with a Runge–
Kutta scheme, solved through ode45 of MatLab. The state system with an initial guess is solved forward in
time and then the adjoint system with the transversality conditions is solved backward in time. The controls
are updated at the end of each iteration (see [7] for more details). Figure 1a) shows the optimal control
obtained by the two different approaches. They both seem to have the same behavior. Table 1 shows the
costs obtained by the two methods, in three situations: optimal control, no control (u(t)  0) and upper
control (u(t) 1). Figure 1b) shows the number of infected humans when different controls are considered.
It is possible to see that the upper control, which means that everyone is vaccinated, implies that just a few
FIGURE 1. a)Optimal control with direct and indirect approaches. b) Infected humans using different levels of control.
individuals were infected, allowing eradication of the disease. Although the optimal control, in the sense of
objective (2), allows the occurrence of an outbreak, the number of infected individuals is much lower when
compared with a situation where no one is vaccinated. Also, the costs are very low when compared with the
upper control case.
CONCLUSIONS
Dengue is an infectious tropical disease difficult to prevent and manage. Researchers agree that the devel-
opment of a vaccine for dengue is a question of high priority. In the present study we show how a vaccine
results in saving lives and at the same time in a reduction of the budget related with the disease. As future
work we intend to study the interaction of a dengue vaccine with other kinds of control already investigated
in the literature, such as insecticide and educational campaigns [8, 9].
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